Recent

% | $
Quotes you view appear here for quick access.

Endocyte, Inc. Message Board

  • sunshinecamesoftly2002 sunshinecamesoftly2002 Feb 19, 2013 9:05 AM Flag

    Many Markets for Endocyte

    Merck has/will continue development of Vintafolate for at least 4 additional targets. Folate is highly expressed in70 % of tumors which represents a huge market. In addition this is only one of several personalized medicine products it has in development. ECYT has a enormous platform with mind boggling potential

 
ECYT
5.28+0.09(+1.73%)Aug 28 4:00 PMEDT